DEERFIELD MANAGEMENT COMPANY, L.P.

Holdings History for ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)

Symbol: SPRY on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 7,610,217 shares
Security Ownership %: 7.8%

Shares, Excluding Options vs Price

Value, Excluding Options

Deerfield Management Company, L.P. ownership in ARS Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (SPRY)

01 Aug 2025 - Deerfield Management Company, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 7,610,217 shares of ARS Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (SPRY). This represents 7.8% ownership of the company. In their previous filing dated 22 Jul 2025, DEERFIELD MANAGEMENT COMPANY, L.P. had reported owning 8,633,537 shares, indicating a decrease of +12%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Deerfield Management Company, L.P.	7.8%	-12%	$134,624,739	7,610,217	-1,023,320	-12%	$17.69	13D/A	30 Jul 2025	01 Aug 2025, 18:06
Deerfield Management Company, L.P.	8.8%	-11%	$150,656,084	8,633,537	-1,090,971	-11%	$17.45	13D/A	18 Jul 2025	22 Jul 2025, 19:38
Deerfield Management Company, L.P.	9.9%	-7.5%	$140,032,915	9,724,508	-790,149	-7.5%	$14.40	13D/A	02 Jul 2025	02 Jul 2025, 08:24
Deerfield Management Company, L.P.	11%		$153,934,578	10,514,657			$14.64	13D/A	20 Mar 2025	24 Mar 2025, 19:57

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	1.1%	0%	$87,419,410	7,503,812	0		$11.65	Q4 2025
30 Sep 2025	1.2%	-0.34%	$75,413,311	7,503,812	-2,220,696	-23%	$10.05	Q3 2025
30 Jun 2025	3.1%	-0.25%	$169,692,665	9,724,508	-790,149	-7.5%	$17.45	Q2 2025
31 Mar 2025	2.6%	0%	$132,274,385	10,514,657	0		$12.58	Q1 2025
31 Dec 2024	2.1%	-0.11%	$110,929,631	10,514,657	-563,270	-5.1%	$10.55	Q4 2024
30 Sep 2024	2.4%	0%	$160,629,942	11,077,927	0		$14.50	Q3 2024
30 Jun 2024	1.6%	0%	$94,273,159	11,077,927	0		$8.51	Q2 2024
31 Mar 2024	2%	0%	$113,216,414	11,077,927	0		$10.22	Q1 2024
31 Dec 2023	1.1%	0%	$60,707,040	11,077,927	0		$5.48	Q4 2023
30 Sep 2023	0.92%	0%	$41,874,564	11,077,927	0		$3.78	Q3 2023
30 Jun 2023	1.6%	0%	$74,222,111	11,077,927	0		$6.70	Q2 2023
31 Mar 2023	1.6%	0%	$72,117,305	11,077,927	0		$6.51	Q1 2023
31 Dec 2022	2%	+2%	$94,494,717	11,077,927	+11,077,927	NEW	$8.53	Q4 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.